- Home
- FMAO vs PACB Comparison
FMAO vs PACB Comparison
Compare FMAO & PACB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FMAO
- PACB
- Stock Information
- Founded
- FMAO 1897
- PACB 2000
- Country
- FMAO United States
- PACB United States
- Employees
- FMAO N/A
- PACB N/A
- Industry
- FMAO Savings Institutions
- PACB Biotechnology: Laboratory Analytical Instruments
- Sector
- FMAO Finance
- PACB Industrials
- Exchange
- FMAO Nasdaq
- PACB Nasdaq
- Market Cap
- FMAO 344.8M
- PACB 364.2M
- IPO Year
- FMAO N/A
- PACB 2010
- Fundamental
- Price
- FMAO $22.83
- PACB $1.00
- Analyst Decision
- FMAO Hold
- PACB Buy
- Analyst Count
- FMAO 1
- PACB 9
- Target Price
- FMAO $26.00
- PACB $2.34
- AVG Volume (30 Days)
- FMAO 12.7K
- PACB 9.8M
- Earning Date
- FMAO 07-31-2025
- PACB 05-08-2025
- Dividend Yield
- FMAO 3.88%
- PACB N/A
- EPS Growth
- FMAO 26.69
- PACB N/A
- EPS
- FMAO 2.01
- PACB N/A
- Revenue
- FMAO $104,144,000.00
- PACB $152,357,000.00
- Revenue This Year
- FMAO N/A
- PACB $4.01
- Revenue Next Year
- FMAO $6.16
- PACB $18.54
- P/E Ratio
- FMAO $11.41
- PACB N/A
- Revenue Growth
- FMAO 9.24
- PACB N/A
- 52 Week Low
- FMAO $19.95
- PACB $0.85
- 52 Week High
- FMAO $34.15
- PACB $2.72
- Technical
- Relative Strength Index (RSI)
- FMAO 40.12
- PACB 44.98
- Support Level
- FMAO $23.27
- PACB $0.85
- Resistance Level
- FMAO $24.49
- PACB $1.10
- Average True Range (ATR)
- FMAO 0.93
- PACB 0.09
- MACD
- FMAO -0.27
- PACB 0.01
- Stochastic Oscillator
- FMAO 5.57
- PACB 50.00
About FMAO Farmers & Merchants Bancorp Inc.
Farmers & Merchants Bancorp Inc is a holding company for Farmers & Merchants Bank of Central California. The company is engaged in general commercial banking business. The activities of the company include commercial, agricultural and residential mortgages as well as consumer and credit card lending activities.
About PACB Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.